PT-141 dosage male research studies used 10 mg to 20 mg injected under the skin. See trial doses, mL math, side effects, and why no male product is approved.
Published research on PT-141 in men has used single subcutaneous doses of 10 mg and 20 mg, given roughly 45 minutes before sexual activity. Bremelanotide, the drug behind PT-141, is not FDA-approved for men in the United States. The only approved product, Vyleesi, is a 1.75 mg auto-injector for premenopausal women with hypoactive sexual desire disorder.
What PT-141 Actually Is
PT-141 is the research name for bremelanotide, a synthetic peptide that activates melanocortin receptors in the brain. It was first studied as a tanning agent, and the trial participants who reported unexpected increases in sexual desire are the reason it became a sexual medicine drug instead.
Unlike PDE5 inhibitors such as sildenafil, bremelanotide works on the central nervous system rather than on blood flow inside the penis. That difference is why it is usually described as a desire drug rather than a performance drug.
PT-141 Dosage Male: What the Trials Reported
Most male data come from small phase 2 trials, not from a labeled men's product. Readers searching for pt-141 dosage male information almost always land on the same two numbers: 10 mg and 20 mg, injected under the skin.
| Dose | Route | What researchers reported | Common side effects |
|---|---|---|---|
| 1.75 mg | Subcutaneous auto-injector | Approved dose for premenopausal women; never established as a men's dose | Nausea, flushing, headache |
| 10 mg | Subcutaneous injection | Improved erectile rigidity in early male trials | Nausea, flushing, injection site reaction |
| 20 mg | Subcutaneous injection | Similar or slightly stronger effect in some trials | Higher rates of nausea, vomiting, and blood pressure rise |
| 10-20 mg | Intranasal (older formulation) | Mixed results; absorption was inconsistent | Nasal irritation, nausea |
In those studies, a higher dose was not reliably better. The 20 mg arm often produced more nausea and flushing without a matching gain in effect, which is a pattern seen across melanocortin drugs.
Approved Dosing vs. Research Dosing
The approved pt-141 dosage for women is 1.75 mg injected into the thigh or abdomen, no more than once in 24 hours and no more than eight times per month.
That is roughly six to eleven times lower than the doses used in male trials. The size of that gap matters, because side effects scale with dose and there is no approved male product to fall back on if something goes wrong.
PT-141 Dosage in mL and Reconstitution Math
The approved product is a prefilled auto-injector, so nothing gets mixed. Compounded or research-grade vials are a different story, and pt-141 dosage in ml depends entirely on how much diluent is added.
The math is simple. A 10 mg vial dissolved in 1 mL of bacteriostatic water gives 10 mg per mL, so a 10 mg dose is 1 mL of solution.
| Vial size | Diluent added | Concentration | Volume for a 10 mg dose |
|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | 1.0 mL |
| 10 mg | 2 mL | 5 mg/mL | 2.0 mL |
| 10 mg | 3 mL | 3.3 mg/mL | 3.0 mL |
When people ask about pt-141 reconstitution and dosage, they often assume the number printed on the syringe equals the dose. It does not. Concentration is what converts milliliters into milligrams, and a mistake there can multiply or divide the intended dose.
Timing, Duration, and Side Effects
In clinical trials, bremelanotide was injected about 45 minutes before sexual activity, and reported effects generally lasted one to three hours. Food does not appear to change absorption the way it does with some oral erectile dysfunction drugs.
The side effect profile is the main reason people stop using it:
- Nausea, the most frequently reported effect and usually the most bothersome
- Flushing, warmth, or redness across the face and neck
- Headache and dizziness
- Injection site pain, bruising, or irritation
- A temporary rise in blood pressure that typically returns to baseline within 12 hours
- Darkening of the skin, gums, or freckles with repeated use
Safety, Legal Status, and Who Should Avoid It
PT-141 is not FDA-approved for men, so any male use is off-label at best. Vials sold as research chemicals are not inspected for purity, sterility, or actual peptide content, and independent testing has repeatedly found underdosed or mislabeled peptides in that market.
Bremelanotide carries a boxed warning about blood pressure increases and is contraindicated in people with uncontrolled hypertension or known cardiovascular disease. Alcohol, nitrates, and some blood pressure medications can interact with it, so a prescriber should review the full medication list before anyone considers a dose.
What About Bodybuilding and Forum Protocols?
Conversations about pt-141 dosage bodybuilding usually center on libido during a cycle of anabolic steroids rather than on muscle growth. There is no evidence that PT-141 builds muscle, improves athletic performance, or changes body composition in any measurable way.
Some users stack it with other peptides and testosterone, which makes side effects harder to trace and raises the chance of an interaction nobody has studied. Stacking also makes it nearly impossible to tell which compound caused a blood pressure spike.
What to Do Instead of Self-Dosing
If the underlying problem is erectile function, FDA-approved options such as PDE5 inhibitors have far more male data behind them. If the issue is low desire, a clinician can evaluate testosterone, current medications, sleep, mood, and relationship factors that often explain the symptom.
Anyone still considering PT-141 should talk with a healthcare professional rather than guessing from a vial. Bring the exact product name, concentration per mL, and planned dose to that conversation so the risk can be assessed realistically.
Frequently Asked Questions
What is the typical PT-141 dosage for men?
There is no approved male dose. Published trials in men used 10 mg and 20 mg injected under the skin, and 10 mg is often described as the better-tolerated research dose. The 20 mg arm produced more nausea and flushing without a clear gain in benefit.
Is PT-141 FDA-approved for men?
No. Bremelanotide is approved in the United States only as Vyleesi, a 1.75 mg auto-injector for premenopausal women with hypoactive sexual desire disorder. Male use is off-label and is not supported by any FDA-approved product label.
How long before sex should PT-141 be taken?
In clinical trials, bremelanotide was injected about 45 minutes before sexual activity, and reported effects generally lasted one to three hours. The approved product is limited to one dose in any 24-hour period and no more than eight doses per month.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.